Online Matchmaking: EP PerMed Twinning Call 2026

25 Sept 2025 – 26 Feb 2026

Register
Register
Register

ExpertiseUpdated on 25 October 2025

Doctor of Medicine, Cardiology specialist

MD, Chief Medical Officer at PARAL at PARAL

Liverpool, United Kingdom

About

I am a an MD, MRCP, and cardiology specialist based in the UK with 10 years of experience as a registered doctor, combining a strong foundation in clinical medicine with a growing focus on digital health and medical technology innovation. My background spans acute, interventional, and outpatient cardiology, giving me a comprehensive understanding of patient pathways and the challenges of modern cardiovascular care.

Alongside my clinical work, I serve as Chief Medical Officer at PARAL, a Copenhagen-based medtech company developing a wearable 12-lead ECG vest for remote cardiac monitoring and early arrhythmia detection. In this role, I lead the clinical and translational components of product development, collaborating with engineers, data scientists, and regulatory teams to ensure the device is both clinically effective and user-centred. I oversee validation studies, guide protocol design, and translate clinical feedback into functional product improvements.

My motivation to engage in medtech innovation arises from real-world experience in cardiology, where I have seen how gaps in early diagnosis, data sharing, and continuity of care can compromise patient outcomes. I believe technology, when applied responsibly, can help address these gaps by improving diagnostic precision, enabling continuous monitoring, and supporting better-informed decision-making for both clinicians and patients.

Through my work at PARAL, I have developed a strong understanding of digital biomarker development, clinical data governance, interoperability, and cross-disciplinary collaboration. My long-term goal is to contribute to the safe and meaningful integration of advanced digital technologies into cardiology practice, fostering innovation that enhances clinical workflows and expands access to high-quality care worldwide.

Field

  • Patient management systems (decision-support tools, clinical workflows)
  • Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
  • Implementation of CE-marked digital health solutions (AI algorithms, software, apps)
  • Clinical decision support systems for personalised medicine
  • Standardisation & evaluation methodologies (protocols, metrics, QA/QC processes)
  • Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
  • Full adoption/acquisition of a PM solution into clinical practice
  • Theranostics (combined diagnostic + therapeutic approaches)

Similar opportunities

  • Expertise

    Advancing Personalized Medicine Through Integrative Research and Clinical Excellence

    • Receiver institution with a need to adopt a PM approach
    • Clinical decision support systems for personalised medicine
    • Theranostics (combined diagnostic + therapeutic approaches)
    • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Patient management systems (decision-support tools, clinical workflows)
    • Partial adoption of a PM solution (testing selected modules/components)
    • Tools for secure data sharing & secondary use (pseudonymisation, FAIR data)
    • Screening & early detection programs (risk stratification, predictive tools)
    • Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
    • Cultural/organisational change approaches (staff training, workflow redesign)
    • Data integration & interoperability solutions (EHRs, registries, data platforms)
    • Standardisation & evaluation methodologies (protocols, metrics, QA/QC processes)
    • Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
    • Patient engagement & empowerment strategies (self-management tools, shared decision-making)
    • Adaptation of an existing PM solution to local context (language, IT environment, regulations)
    • Initiating implementation of a PM solution (pilot site setup, proof-of-concept in clinical practice)

    Inês Costa

    Research Manager at Universidade de Coimbra - Faculdade de Coimbra

    Coimbra, Portugal

  • Expertise

    Advisory services on the implementation of 3D printing technology in public and private hospitals.

    • Donor institution with a ready PM approach
    • Receiver institution with a need to adopt a PM approach
    • Clinical decision support systems for personalised medicine
    • Full adoption/acquisition of a PM solution into clinical practice
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Patient management systems (decision-support tools, clinical workflows)
    • Partial adoption of a PM solution (testing selected modules/components)
    • Screening & early detection programs (risk stratification, predictive tools)
    • Cultural/organisational change approaches (staff training, workflow redesign)
    • Reimbursement-ready approaches (integration with public health insurance systems)
    • Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
    • Patient engagement & empowerment strategies (self-management tools, shared decision-making)
    • Adaptation of an existing PM solution to local context (language, IT environment, regulations)
    • Initiating implementation of a PM solution (pilot site setup, proof-of-concept in clinical practice)

    Jesús Corbacho

    Medical Advisor on 3D Printing Integration in Clinical Environments. at Eureqa 3D

    Cáceres, Spain

  • Expertise

    Citogenetics and Functional Genomics

    • Receiver institution with a need to adopt a PM approach
    • Clinical decision support systems for personalised medicine
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Patient management systems (decision-support tools, clinical workflows)
    • Screening & early detection programs (risk stratification, predictive tools)
    • Adaptation of care pathways for PM (embedding new tests/therapies into routine care)

    Inês Costa

    Research Manager at Universidade de Coimbra - Faculdade de Coimbra

    Coimbra, Portugal